A Novel Series of Potent and Selective Ketone Histone Deacetylase Inhibitors with Antitumor Activity in Vivo
- 28 March 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (8) , 2350-2353
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Histone Deacetylase Inhibitors: From Bench to ClinicJournal of Medicinal Chemistry, 2008
- VorinostatNature Reviews Drug Discovery, 2007
- Chromatin Remodeling, Cancer and ChemotherapyCurrent Medicinal Chemistry, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Chromatin modifier enzymes, the histone code and cancerEuropean Journal of Cancer, 2005
- Histone deacetylases (HDACs): characterization of the classical HDAC familyBiochemical Journal, 2003
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Acetylation and chromosomal functionsCurrent Opinion in Cell Biology, 2000